Literature DB >> 14507888

Morphological changes in the anterior eye segment after long-term treatment with different receptor selective prostaglandin agonists and a prostamide.

Markus Richter1, Achim H-P Krauss, David F Woodward, Elke Lütjen-Drecoll.   

Abstract

PURPOSE: To investigate long-term changes in the anterior segment of primate eyes treated for one year with different prostaglandin agonists and a prostamide. The results were compared with those obtained after vehicle treatment and in untreated controls.
METHODS: Sixteen young cynomolgus monkeys were unilaterally topically treated for 1 year with either bimatoprost 0.03% (prostamide), sulprostone 0.03% (EP(3)/EP(1) agonist), AH13205 0.1% (EP(2) agonist), or latanoprost 0.005% (FP agonist), which all lower IOP in this species at the doses applied. Four animals were treated with the vehicle only. In all cases the left eye was treated, the right eye remained untreated. Six monkeys served as untreated controls. Sections from 4 quadrants each of the circumference of the eyes of 16 drug-treated, 4 vehicle-treated and 6 untreated control animals were investigated qualitatively and quantitatively using light- and electronmicroscopy. The area of widened spaces between ciliary muscle bundles, the number of nerve fiber bundles at the muscle tips, and the width and length of the ciliary muscle were quantitated.
RESULTS: The general morphology of the ciliary muscle and trabecular meshwork was normal in appearance and shape in all animals, whereas some localized morphologic changes were observed in the drug-treated animals. The changes were found to be similar in all four treatment groups. In the ciliary muscle, there was a significant increase in optically empty spaces between muscle bundles in the anterior portion of the longitudinal and the reticular ciliary muscle compared with untreated and vehicle-treated control animals. Within these spaces, significantly more myelinated nerve fiber bundles were found in drug-treated compared with normal control animals. Ultrastructurally the spaces were partly covered by endothelial-like cells which, in some areas, were in contact with the basement membrane of the microvasculature. In all treatment groups, there were also changes in the trabecular meshwork region. Significant regional differences among the different quadrants of the eyes and quantitative differences between treatment groups were observed. The ciliary epithelium had a normal appearance in all treatment groups.
CONCLUSIONS: After one year of treatment with different prostaglandins and a prostamide, uveoscleral outflow pathways are enlarged and appear organized. Conventional outflow routes were also affected. Long-term treatment with AH13205, latanoprost, sulprostone, or bimatoprost also induces sprouting of nerve fibers.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 14507888     DOI: 10.1167/iovs.02-1281

Source DB:  PubMed          Journal:  Invest Ophthalmol Vis Sci        ISSN: 0146-0404            Impact factor:   4.799


  38 in total

1.  Upregulation of orphan nuclear receptor Nur77 following PGF(2alpha), Bimatoprost, and Butaprost treatments. Essential role of a protein kinase C pathway involved in EP(2) receptor activated Nur77 gene transcription.

Authors:  Yanbin Liang; Chen Li; Victor M Guzman; William W Chang; Albert J Evinger; Jozelyn V Pablo; David F Woodward
Journal:  Br J Pharmacol       Date:  2004-05-24       Impact factor: 8.739

Review 2.  [Primary open angle glaucoma. Morphological bases for the understanding of the pathogenesis and effects of antiglaucomatic substances].

Authors:  E Lütjen-Drecoll; F E Kruse
Journal:  Ophthalmologe       Date:  2007-02       Impact factor: 1.059

3.  Prostaglandin subtype-selective and non-selective IOP-lowering comparison in monkeys.

Authors:  B'Ann True Gabelt; Elizabeth A Hennes; Mark A Bendel; Chase E Constant; Mehmet Okka; Paul L Kaufman
Journal:  J Ocul Pharmacol Ther       Date:  2009-02       Impact factor: 2.671

Review 4.  Prospects for lentiviral vector mediated prostaglandin F synthase gene delivery in monkey eyes in vivo.

Authors:  Eun Suk Lee; Carol A Rasmussen; Mark S Filla; Sarah R Slauson; Aaron W Kolb; Donna M Peters; Paul L Kaufman; B'Ann T Gabelt; Curtis R Brandt
Journal:  Curr Eye Res       Date:  2014-02-21       Impact factor: 2.424

5.  Prostaglandins increase trabecular meshwork outflow facility in cultured human anterior segments.

Authors:  Cindy K Bahler; Kyle G Howell; Cheryl R Hann; Michael P Fautsch; Douglas H Johnson
Journal:  Am J Ophthalmol       Date:  2007-11-07       Impact factor: 5.258

6.  Latanoprost-induced changes in rat intraocular pressure: direct or indirect?

Authors:  Shahid Husain; Phillip W Yates; Craig E Crosson
Journal:  J Ocul Pharmacol Ther       Date:  2008-08       Impact factor: 2.671

7.  Secreted protein acidic and rich in cysteine (SPARC)-null mice exhibit more uniform outflow.

Authors:  Swarup S Swaminathan; Dong-Jin Oh; Min Hyung Kang; Ruiyi Ren; Rui Jin; Haiyan Gong; Douglas J Rhee
Journal:  Invest Ophthalmol Vis Sci       Date:  2013-03-21       Impact factor: 4.799

8.  First-line treatment for elevated intraocular pressure (IOP) associated with open-angle glaucoma or ocular hypertension: focus on bimatoprost.

Authors:  Simon K Law
Journal:  Clin Ophthalmol       Date:  2007-09

9.  Bimatoprost effects on aqueous humor dynamics in monkeys.

Authors:  David F Woodward; Achim H-P Krauss; Siv F E Nilsson
Journal:  J Ophthalmol       Date:  2010-05-23       Impact factor: 1.909

10.  Clinical utility and differential effects of prostaglandin analogs in the management of raised intraocular pressure and ocular hypertension.

Authors:  Anne J Lee; Peter McCluskey
Journal:  Clin Ophthalmol       Date:  2010-07-30
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.